Author
Listed:
- Huijun Shi
(College of Food Sciences and Technology, Shanghai Ocean University, Shanghai 201306, China)
- Lin Chen
(College of Food Sciences and Technology, Shanghai Ocean University, Shanghai 201306, China)
- Zhaohuan Zhang
(College of Food Sciences and Technology, Shanghai Ocean University, Shanghai 201306, China)
- Yong Zhao
(College of Food Sciences and Technology, Shanghai Ocean University, Shanghai 201306, China
Shanghai Engineering Research Center of Aquatic Product Processing & Preservation, Shanghai 201306, China
Laboratory of Quality and Safety Risk Assessment for Aquatic Product on Storage and Preservation, Ministry of Agriculture and Rural Affairs, Shanghai 201306, China)
- Jie Ou
(College of Food Sciences and Technology, Shanghai Ocean University, Shanghai 201306, China
Shanghai Engineering Research Center of Aquatic Product Processing & Preservation, Shanghai 201306, China
Laboratory of Quality and Safety Risk Assessment for Aquatic Product on Storage and Preservation, Ministry of Agriculture and Rural Affairs, Shanghai 201306, China)
Abstract
Aflatoxin B1 (AFB 1 ) –induced liver damage may be treated with chitosan oligosaccharide (COS), a small-molecular–weight oligosaccharide with excellent bioactivity and antioxidant potential. Hepatotoxicity induced by AFB 1 single acute exposure (ASAE) has been theoretically established but the mechanism of toxicity in aquatic models has been less studied. In this paper, a model of liver injury in Japanese medaka ( Oryzias latipes ) after ASAE for 72 h and a model of liver injury healing after ASAE following a COS intervention for 72 h were developed. The different effects of ASAE and COS interventions for ASAE were analyzed at the phenotypic and genetic levels. The results showed that AFB 1 reduced body weight and hepatopancreatic somatic indices (HSI) in medaka. Moreover, AFB 1 –induced histopathological damage and oxidative stress injury were concentration–dependent but the symptoms of damage were attenuated to some extent by the addition of the intervention drug COS, and the intervention effect of high concentrations of COS was almost identical to silymarin (SIL). Using the RNA–Seq technique, COS reduces the number of differentially expressed genes (DEGs) brought about by AFB 1 . Among the genes associated with tumors, hepatocellular carcinoma and hepatitis aurka , thbs1 , serpine1 , fabp7 , and dusp5 were also validated by Q-PCR with corresponding trends. In conclusion, AFB 1 can cause liver injury in medaka and COS has a therapeutic effect, and these impacted genes have the potential to become therapeutic targets for COS intervention in AFB 1 –induced liver disease.
Suggested Citation
Huijun Shi & Lin Chen & Zhaohuan Zhang & Yong Zhao & Jie Ou, 2023.
"COS Attenuates AFB 1 -Induced Liver Injury in Medaka through Inhibition of Histopathological Damage and Oxidative Stress,"
Sustainability, MDPI, vol. 15(6), pages 1-12, March.
Handle:
RePEc:gam:jsusta:v:15:y:2023:i:6:p:5418-:d:1101215
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jsusta:v:15:y:2023:i:6:p:5418-:d:1101215. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.